ENO1 and rheumatoid arthritis: PTSG2, ENO1, GRN were screened and validated, and their expression characteristics and possible regulatory mechanisms in RA were discussed using bioinformatics analysis and in vitro as shown in Figure 1, with the expectation of providing a new approach for RA diagnosis and treatment.